These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36581723)
41. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer. Kang JG; Choi JE; Kang SH World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912 [TBL] [Abstract][Full Text] [Related]
42. Recurrence in regional lymph nodes after total thyroidectomy and neck dissection in patients with papillary thyroid cancer. Joo JY; Jin J; Seo ST; Lim YC; Rha KS; Koo BS Oral Oncol; 2015 Feb; 51(2):164-9. PubMed ID: 25435434 [TBL] [Abstract][Full Text] [Related]
43. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713 [TBL] [Abstract][Full Text] [Related]
44. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma. Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026 [TBL] [Abstract][Full Text] [Related]
45. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion. Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682 [No Abstract] [Full Text] [Related]
46. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis. Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273 [TBL] [Abstract][Full Text] [Related]
47. Is multifocality a risk factor in low-risk papillary thyroid cancer? Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871 [TBL] [Abstract][Full Text] [Related]
48. Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance. Ding W; Ruan G; Lin Y; Zhu J; Li Z; Ye D Front Endocrinol (Lausanne); 2023; 14():1235006. PubMed ID: 37745712 [TBL] [Abstract][Full Text] [Related]
49. Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma. Park JS; Chang JW; Liu L; Jung SN; Koo BS Oral Oncol; 2017 Sep; 72():183-187. PubMed ID: 28222967 [TBL] [Abstract][Full Text] [Related]
50. Clinicopathological features of incidentally detected metastatic thyroid papillary carcinoma in cervical lymph nodes of non-thyroid cancer patients: a retrospective analysis of 31cases. Hu C; Zhang H; Chu L; Qiu T; Lu H Diagn Pathol; 2023 Jul; 18(1):82. PubMed ID: 37454141 [TBL] [Abstract][Full Text] [Related]
51. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Smulever A; Pitoia F Arch Endocrinol Metab; 2019; 63(5):462-469. PubMed ID: 31482955 [TBL] [Abstract][Full Text] [Related]
52. The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma. Pyo JS; Kang G; Kim DH; Park C; Kim JH; Sohn JH World J Surg; 2013 Oct; 37(10):2330-5. PubMed ID: 23716027 [TBL] [Abstract][Full Text] [Related]
53. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma. Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594 [TBL] [Abstract][Full Text] [Related]
54. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
55. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm. Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022 [TBL] [Abstract][Full Text] [Related]
56. Association of patient age with high-risk pathologic features in papillary thyroid cancer. Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122 [TBL] [Abstract][Full Text] [Related]
57. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism. Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715 [TBL] [Abstract][Full Text] [Related]
58. Clinical significance of extrathyroidal extension to major vessels in papillary thyroid carcinoma. Abuduwaili M; Su A; Xing Z; Xia B; Wu Z; Fei Y; Zhu J; Chen Z J Endocrinol Invest; 2023 Jun; 46(6):1155-1167. PubMed ID: 36427135 [TBL] [Abstract][Full Text] [Related]
59. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related]
60. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]